California Public Employees Retirement System Magenta Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$9.76 - $14.15 $325,984 - $472,610	-33,400 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$7.66 - $13.38 $29,475 - $51,486	-3,848 Reduced 10.33%	33,400 $395,000
Q4 2020 Feb 02, 2021	SELL	$6.1 - $7.94 $5,490 - $7,146	-900 Reduced 2.36%	37,248 $292,000
Q3 2020 Nov 05, 2020	BUY	$6.52 - $8.94 $25,088 - $34,401	3,848 Added 11.22%	38,148 $259,000
Q2 2020 Aug 12, 2020	BUY	$6.18 - $10.76 $6 - $10	1 Added 0.0%	34,300 $258,000
Q4 2019 Jan 27, 2020	BUY	$9.07 - $15.84 $311,091 - $543,296	34,299 New	34,299 $520,000

Others Institutions Holding MGTA

# of Institutions

Shares Held

442K

Call Options Held

Put Options Held

Hellman Jordan Management CO Inc Quincy, MA

441K
Shares

$0
0.3% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.3K
Shares

$0
0.0% of portfolio

View Full List

About Magenta Therapeutics, Inc.

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

More about MGTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account